Literature DB >> 16311512

Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.

H Fujimoto1, N Onishi, N Kato, M Takekawa, X Z Xu, A Kosugi, T Kondo, M Imamura, I Oishi, A Yoda, Y Minami.   

Abstract

The antioncogenic Chk2 kinase plays a crucial role in DNA damage-induced cell-cycle checkpoint regulation. Here we show that Chk2 associates with the oncogenic protein Wip1 (wild-type p53-inducible phosphatase 1) (PPM1D), a p53-inducible protein phosphatase. Phosphorylation of Chk2 at threonine68 (Thr68), a critical event for Chk2 activation, which is normally induced by DNA damage or overexpression of Chk2, is inhibited by expression of wild-type (WT), but not a phosphatase-deficient mutant (D314A) of Wip1 in cultured cells. Furthermore, an in vitro phosphatase assay revealed that Wip1 (WT), but not Wip1 (D314A), dephosphorylates Thr68 on phosphorylated Chk2 in vitro, resulting in the inhibition of Chk2 kinase activity toward glutathione S-transferase-Cdc25C. Moreover, inhibition of Wip1 expression by RNA interference results in abnormally sustained Thr68 phosphorylation of Chk2 and increased susceptibility of cells in response to DNA damage, indicating that Wip1 acts as a negative regulator of Chk2 in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311512     DOI: 10.1038/sj.cdd.4401801

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  84 in total

1.  The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.

Authors:  Thuy-Ai Nguyen; Scott D Slattery; Sung-Hwan Moon; Yolanda F Darlington; Xiongbin Lu; Lawrence A Donehower
Journal:  DNA Repair (Amst)       Date:  2010-05-06

Review 2.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

Review 3.  Crosstalk between the DNA damage response pathway and microRNAs.

Authors:  Cecil Han; Guohui Wan; Robert R Langley; Xinna Zhang; Xiongbin Lu
Journal:  Cell Mol Life Sci       Date:  2012-03-20       Impact factor: 9.261

4.  Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response.

Authors:  Hyukjin Cha; Julie M Lowe; Henghong Li; Ji-Seon Lee; Galina I Belova; Dmitry V Bulavin; Albert J Fornace
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

5.  Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents.

Authors:  Anastasia R Goloudina; Kan Tanoue; Arlette Hammann; Eric Fourmaux; Xavier Le Guezennec; Dmitry V Bulavin; Sharlyn J Mazur; Ettore Appella; Carmen Garrido; Oleg N Demidov
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

6.  Mechanisms of checkpoint kinase Rad53 inactivation after a double-strand break in Saccharomyces cerevisiae.

Authors:  Ghislaine Guillemain; Emilie Ma; Sarah Mauger; Simona Miron; Robert Thai; Raphaël Guérois; Françoise Ochsenbein; Marie-Claude Marsolier-Kergoat
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

7.  Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.

Authors:  Yun Xia; Pat Ongusaha; Sam W Lee; Yih-Cherng Liou
Journal:  J Biol Chem       Date:  2009-04-24       Impact factor: 5.157

8.  Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.

Authors:  Libor Macurek; Jan Benada; Erik Müllers; Vincentius A Halim; Kateřina Krejčíková; Kamila Burdová; Sona Pecháčková; Zdeněk Hodný; Arne Lindqvist; René H Medema; Jiri Bartek
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

9.  p53 Regulates LIF expression in human medulloblastoma cells.

Authors:  Euan W Baxter; Jo Milner
Journal:  J Neurooncol       Date:  2009-11-12       Impact factor: 4.130

10.  Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.

Authors:  Huy Q Ta; Melissa L Ivey; Henry F Frierson; Mark R Conaway; Jaroslaw Dziegielewski; James M Larner; Daniel Gioeli
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.